A recent study showed that IL-6 production from α-SMA+ myCAFs, but not pCAFs, marked by the expression of fibroblast activation protein-α (FAP-α), contributes to the resistance of pancreatic cancer to chemotherapy and ICIs (Figure 2) [56]. Here, ACTA1 is linked to pancreatic neoplasm.